We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INN
1901
Summit Hotel Properties
INN
$766M
| $731K | ﹤0.01% |
62,672
+4,450
| +8% | +$56.8K |
|
|
WSTC
1902
DELISTED
West Corporation
WSTC
| $730K | ﹤0.01% |
32,586
+409
| +1% | +$10.8K |
|
1903
UFP Industries
UFPI
$4.95B
| $729K | ﹤0.01% |
37,905
-1,599
| -4% | -$31.8K |
|
|
MRC
1904
DELISTED
MRC Global
MRC
| $728K | ﹤0.01% |
65,280
-2,101
| -3% | -$27.4K |
|
|
CYS
1905
DELISTED
CYS Investments Inc.
CYS
| $726K | ﹤0.01% |
100,052
-6,565
| -6% | -$50.7K |
|
1906
SPS Commerce
SPSC
$2.55B
| $725K | ﹤0.01% |
21,358
-816
| -4% | -$28.5K |
|
|
PAY
1907
DELISTED
Verifone Systems Inc
PAY
| $724K | ﹤0.01% |
26,124
+9,323
| +55% | +$291K |
|
|
PPS
1908
DELISTED
Post Properties
PPS
| $724K | ﹤0.01% |
12,414
+4,362
| +54% | +$250K |
|
|
ZU
1909
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $719K | ﹤0.01% |
41,334
+5,614
| +16% | +$87.1K |
|
|
ASRT
1910
DELISTED
Assertio
ASRT
| $717K | ﹤0.01% |
634
-30
| -5% | -$51.2K |
|
1911
Healthcare Realty
HR
$7.56B
| $717K | ﹤0.01% |
29,245
-11,592
| -28% | -$286K |
|
1912
KB Home
KBH
$3.5B
| $717K | ﹤0.01% |
52,945
-1,634
| -3% | -$24.9K |
|
1913
Benchmark Electronics
BHE
$2.66B
| $716K | ﹤0.01% |
32,900
-1,576
| -5% | -$33.7K |
|
1914
Omnicell
OMCL
$1.88B
| $715K | ﹤0.01% |
23,003
-227,238
| -91% | -$8.14M |
|
1915
Apple Hospitality REIT
APLE
$3.97B
| $714K | ﹤0.01% |
+38,449
| New | +$704K |
|
|
STRZA
1916
DELISTED
Starz - Series A
STRZA
| $713K | ﹤0.01% |
19,084
-288,054
| -94% | -$11.5M |
|
1917
Westamerica Bancorp
WABC
$1.39B
| $712K | ﹤0.01% |
16,024
-552
| -3% | -$26.2K |
|
|
SEM
1918
DELISTED
Select Medical
SEM
| $711K | ﹤0.01% |
122,338
-1,804
| -1% | -$13.4K |
|
|
JBTM
1919
JBT Marel
JBTM
$7.35B
| $711K | ﹤0.01% |
18,598
-309
| -2% | -$11.2K |
|
1920
Popular Inc
BPOP
$11B
| $709K | ﹤0.01% |
23,470
-32,840
| -58% | -$982K |
|
|
MMT
1921
Aberdeen Multi-Market Income Fund
MMT
$237M
| $708K | ﹤0.01% |
126,569
| – | – |
|
|
GWR
1922
DELISTED
Genesee & Wyoming Inc.
GWR
| $707K | ﹤0.01% |
11,972
+4,327
| +57% | +$298K |
|
|
TCF
1923
DELISTED
TCF Financial Corporation Common Stock
TCF
| $706K | ﹤0.01% |
21,816
+234
| +1% | +$7.58K |
|
|
LPNT
1924
DELISTED
LifePoint Health, Inc.
LPNT
| $706K | ﹤0.01% |
9,958
+3,446
| +53% | +$280K |
|
|
BLUE
1925
DELISTED
bluebird bio
BLUE
| $704K | ﹤0.01% |
635
-3,391
| -84% | -$6.18M |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.